Pancreatic Cancer Research

ResearcherThe Royal Free HospitalActive in the last 2 years

Tim Meyer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0782-8647; OpenAlex author ID A5060350068. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2005: 1 trial · 2006: none · 2007: none · 2008: none · 2009: none · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial. Co-author DOI 10.1200/jco.24.01118↗
  2. Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. Co-author DOI 10.1001/jamasurg.2019.3337↗
  3. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-lab… Co-author DOI 10.1016/s0140-6736(16)32409-6↗

Trials 1

  1. Z-360 in Unresectable Advanced Pancreatic Cancer in Combination With Gemcitabine Treatment Principal investigator NCT00288925↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gary Middleton · 3 shared papers, 2017–2025 · strength 0.27
  2. Olusola Olusesan Faluyi · 3 shared papers, 2017–2025 · strength 0.27
  3. Yuk Ting Ma · 3 shared papers, 2017–2025 · strength 0.27
  4. Paula Ghaneh · 3 shared papers, 2017–2025 · strength 0.27
  5. Paul J. Ross · 3 shared papers, 2017–2025 · strength 0.27
  6. Bengt L. G. Glimelius · 3 shared papers, 2017–2025 · strength 0.27
  7. Daniel H. Palmer · 3 shared papers, 2017–2025 · strength 0.27
  8. Thilo Hackert · 3 shared papers, 2017–2025 · strength 0.27
  9. John P. Neoptolemos · 3 shared papers, 2017–2025 · strength 0.27
  10. Pascal R. Hammel · 3 shared papers, 2017–2025 · strength 0.27
  11. David Cunningham · 3 shared papers, 2017–2025 · strength 0.27
  12. Harpreet Singh Wasan · 3 shared papers, 2017–2025 · strength 0.27
  13. Juan W. Valle · 3 shared papers, 2017–2025 · strength 0.27
  14. Christopher Michael Halloran · 3 shared papers, 2017–2025 · strength 0.27
  15. Peter J. Bailey · 1 shared paper, 2025 · strength 0.17
  16. Christoph Springfeld · 1 shared paper, 2025 · strength 0.17
  17. Christoph W. Michalski · 1 shared paper, 2025 · strength 0.17
  18. Alan Anthoney · 2 shared papers, 2017–2019 · strength 0.10
  19. Markus Wolfgang Büchler · 2 shared papers, 2017–2019 · strength 0.10
  20. Derek A O'Reilly · 2 shared papers, 2017–2019 · strength 0.10
  21. Jakob Robert Izbicki · 2 shared papers, 2017–2019 · strength 0.10
  22. Robert Peter Jones · 1 shared paper, 2019 · strength 0.06
  23. Oliver Strobel · 1 shared paper, 2019 · strength 0.06
  24. Julia V. Mayerle · 1 shared paper, 2019 · strength 0.06
  25. Markus M. Lerch · 1 shared paper, 2019 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.